Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hellstern

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Gastroenterology|November 1, 1989
Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trialU Leuschner, H Fischer, W Kurtz, et al.
The American Journal of Gastroenterology|February 1, 1988
Endoscopy of the gallbladder as control of gallstone therapy with methyl-tert-butyl etherU Leuschner, A Hellstern, T Wendt, et al.
Journal of Bacteriology|March 21, 2007
Heterologous expression and identification of the genes involved in anaerobic degradation of 1,3-dihydroxybenzene (resorcinol) in Azoarcus anaerobiusPaula I Darley, Jutta A Hellstern, Javier I Medina-Bellver, et al.
BJU International|November 25, 2003
Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancerM G Friedrich, M I Toma, A Hellstern, et al.
Anaesthesia|February 16, 2005
SNAP index and Bispectral index during different states of propofol/remifentanil anaesthesiaG N Schmidt, P Bischoff, T Standl, et al.
Arzneimittel-Forschung|June 1, 1987
Absolute bioavailability of metoclopramide given orally or by enema in patients with normal liver function or with cirrhosis of the liverA Hellstern, D Hellenbrecht, R Saller, et al.
Clinical Pharmacology and Therapeutics|January 1, 1985
Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesisR Saller, D Hellenbrecht, L Briemann, et al.
Der Urologe. Ausg. A|April 24, 2001
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]S H Hautmann, G L Schroeder, F Civantos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 13, 2019
CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patientsPaul J Pockros, Michael Fuchs, Bradley Freilich, et al.
Journal of Crohn'S & Colitis|February 18, 2021
Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT IIWalter Reinisch, William J Sandborn, Silvio Danese, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Gastroenterology|November 1, 1989
Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trialU Leuschner, H Fischer, W Kurtz, et al.
The American Journal of Gastroenterology|February 1, 1988
Endoscopy of the gallbladder as control of gallstone therapy with methyl-tert-butyl etherU Leuschner, A Hellstern, T Wendt, et al.
Journal of Bacteriology|March 21, 2007
Heterologous expression and identification of the genes involved in anaerobic degradation of 1,3-dihydroxybenzene (resorcinol) in Azoarcus anaerobiusPaula I Darley, Jutta A Hellstern, Javier I Medina-Bellver, et al.
BJU International|November 25, 2003
Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancerM G Friedrich, M I Toma, A Hellstern, et al.
Anaesthesia|February 16, 2005
SNAP index and Bispectral index during different states of propofol/remifentanil anaesthesiaG N Schmidt, P Bischoff, T Standl, et al.
Arzneimittel-Forschung|June 1, 1987
Absolute bioavailability of metoclopramide given orally or by enema in patients with normal liver function or with cirrhosis of the liverA Hellstern, D Hellenbrecht, R Saller, et al.
Clinical Pharmacology and Therapeutics|January 1, 1985
Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesisR Saller, D Hellenbrecht, L Briemann, et al.
Der Urologe. Ausg. A|April 24, 2001
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]S H Hautmann, G L Schroeder, F Civantos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 13, 2019
CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patientsPaul J Pockros, Michael Fuchs, Bradley Freilich, et al.
Journal of Crohn'S & Colitis|February 18, 2021
Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT IIWalter Reinisch, William J Sandborn, Silvio Danese, et al.
Pageof 5